Journal of the American Society of Echocardiography
Volume 22, Issue 12 , Pages 1338-1343 , December 2009

Left Atrial Volume Index: A Predictor of Adverse Outcome in Patients With Hypertrophic Cardiomyopathy

  • Woo-In Yang, MD

      Affiliations

    • Cardiology Division, Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea
    • ,
  • Chi Young Shim, MD, PhD

      Affiliations

    • Cardiology Division, Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea
    • ,
  • Young Jin Kim, MD, PhD

      Affiliations

    • Department of Radiology, Yonsei University College of Medicine, Seoul, Korea
    • ,
  • Sung-Ai Kim, MD

      Affiliations

    • Cardiology Division, Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea
    • ,
  • Sang Jae Rhee, MD

      Affiliations

    • Cardiology Division, Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea
    • ,
  • Eui-Young Choi, MD, PhD

      Affiliations

    • Cardiology Division, Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea
    • ,
  • Donghoon Choi, MD, PhD

      Affiliations

    • Cardiology Division, Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea
    • ,
  • Yangsoo Jang, MD, PhD

      Affiliations

    • Cardiology Division, Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea
    • ,
  • Namsik Chung, MD, PhD

      Affiliations

    • Cardiology Division, Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea
    • ,
  • Seung-Yun Cho, MD, PhD

      Affiliations

    • Cardiology Division, Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea
    • ,
  • Jong-Won Ha, MD, PhD

      Affiliations

    • Cardiology Division, Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea
    • Corresponding Author InformationReprint requests: Jong-Won Ha, MD, PhD, Cardiology Division, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-gu, Seoul 120-752, Korea.

References 

  1. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, et al. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis. 1985;28:1–83
  2. Nihoyannopoulos P, Karatasakis G, Frenneaux M, McKenna WJ, Oakley CM. Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity. J Am Coll Cardiol. 1992;19:536–540
  3. Beinart R, Boyko V, Schwammenthal E, Kuperstein R, Sagie A, Hod H, et al. Long-term prognostic significance of left atrial volume in acute myocardial infarction. J Am Coll Cardiol. 2004;44:327–334
  4. Tsang TS, Barnes ME, Gersh BJ, Takemoto Y, Rosales AG, Bailey KR, et al. Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. J Am Coll Cardiol. 2003;42:1199–1205
  5. Rossi A, Cicoira M, Zanolla L, Sandrini R, Golia G, Zardini P, et al. Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2002;40:1425
  6. Nunes MC, Barbosa M, Ribeiro AL, Colosimo EA, Rocha MO. Left atrial volume provides independent prognostic value in patients with Chagas cardiomyopathy. J Am Soc Echocardiogr. 2009;22:82–88
  7. Lombardi R, Betocchi S, Losi MA, Tocchetti CG, Aversa M, Miranda M, et al. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation. 2003;108:1455–1460
  8. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003;41:1561–1567
  9. Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40:2156–2164
  10. Teraoka K. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging. 2005;23:701
  11. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777–802
  12. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007;298:405–412
  13. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000;342:1778–1785
  14. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 2000;36:2212–2218
  15. Maron BJ, Estes NA, Maron MS, Almquist AK, Link MS, Udelson JE. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation. 2003;107:2872–2875
  16. Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, et al. A mouse model of familial hypertrophic cardiomyopathy. Science. 1996;272:731–734
  17. Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation. 2001;104:128–130
  18. Greenberg B, Chatterjee K, Parmley WW, Werner JA, Holly AN. The influence of left ventricular filling pressure on atrial contribution to cardiac output. Am Heart J. 1979;98:742–751
  19. Pritchett AM, Mahoney DW, Jacobsen SJ, Rodeheffer RJ, Karon BL, Redfield MM. Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol. 2005;45:87–92
  20. Kjaergaard J, Johnson BD, Pellikka PA, Cha SS, Oh JK, Ommen SR. Left atrial index is a predictor of exercise capacity in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2005;18:1373–1380
  21. Sachdev V, Shizukuda Y, Brenneman CL, Birdsall CW, Waclawiw MA, Arai AE, et al. Left atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathy. Am Heart J. 2005;149:730–736
  22. Nistri S, Olivotto I, Betocchi S, Losi MA, Valsecchi G, Pinamonti B, et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am J Cardiol. 2006;98:960–965
  23. Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR, et al. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter?. J Am Coll Cardiol. 2006;47:1018–1023
  24. Yang H, Woo A, Monakier D, Jamorski M, Fedwick K, Wigle ED, et al. Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. J Am Soc Echocardiogr. 2005;18:1074–1082
  25. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104:2517–2524
  26. Chiariello M, Barbati G, Tocchetti C, Cacace A, D'Alessandro G, Miranda M, et al. Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2004;94:895–900
  27. Losi MA, Betocchi S, Barbati G, Parisi V, Tocchetti CG, Pastore F, et al. Prognostic significance of left atrial volume dilatation in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2009;22:76–81
  28. Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, Panse N, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005;112:855–861
  29. Choi DS, Ha JW, Choi B, Yang WI, Choi EY, Rim SJ, et al. Extent of late gadolinium enhancement in cardiovascular magnetic resonance and its relation with left ventricular diastolic function in patients with hypertrophic cardiomyopathy. Circ J. 2008;72:1449–1453
  30. Elliott PM, Gimeno Blanes JR, Mahon NG, Poloniecki JD, McKenna WJ. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet. 2001;357:420–424
  31. Nakagawa H, Inaba Y, Kitabatake A, Morikawa Y, Soyama Y, Matsumori A, et al. Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study. Heart. 2007;93:711–715
  32. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003;348:295–303
  33. Maron BJ, Olivotto I, Maron MS. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?. Eur Heart J. 2006;27:1895–1897
  34. Biagini E, Coccolo F, Ferlito M, Perugini E, Rocchi G, Bacchi-Reggiani L, et al. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. J Am Coll Cardiol. 2005;46:1543–1550

 This work was supported by grant M10642120001-06N4212-00110 from the Korea Science and Engineering Foundation, funded by the Korean government.

PII: S0894-7317(09)00859-1

doi: 10.1016/j.echo.2009.09.016

Journal of the American Society of Echocardiography
Volume 22, Issue 12 , Pages 1338-1343 , December 2009

Article Tools

* Image Usage & Resolution